89 Zr-Immuno-PET with Immune Checkpoint Inhibitors: Measuring Target Engagement in Healthy Organs.
Iris H C MiedemaJessica E WijngaardenJohanna E E PouwGerben J C ZwezerijnenHylke J SebusEgbert SmitAdrianus J de LangenIdris BahceAndrea ThieleDaniëlle J VugtsRonald BoellaardMarc C HuismanC Willemien Menke-van der Houven van OordtPublished in: Cancers (2023)
values with increasing mass doses supports the applicability of Patlak analysis for the assessment of target engagement for PET ligands with irreversible uptake behavior.